idw – Informationsdienst Wissenschaft
Nachrichten, Termine, Experten
Nachrichten, Termine, Experten
At the annual meeting of the German Stem Cell Network (GSCN) in Münster, Claudia Waskow, research group leader at the Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) and Professor of Immunology of Aging at Friedrich Schiller University Jena, was appointed as the new president of the GSCN. In her two-year term, she intends to expand networking with researchers in Europe and worldwide, further strengthen the GSCN’s promotion of young scientists, and provide greater visibility for women in the field.
Jena. The German Stem Cell Network (GSCN) is the platform in Germany for scientists working in the field of stem cell biology. It was founded in 2013 by twelve stem cell researchers and now includes more than 400 researchers and over 30 research institutions and companies. Prof. Dr. Claudia Waskow was appointed as the new president of the GSCN at its 10th annual conference in Münster from September 13 to 16, 2022. The immunologist, who heads the research group “Regeneration in Hematopoiesis: Immunology of Aging” at the Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) and specifically focuses on hematopoietic stem cells, takes over from Prof. Dr. Hans R. Schöler, Director Emeritus at the Max Planck Institute for Molecular Biomedicine in Münster.
Networking is of paramount importance for stem cell research
“The GSCN is the only organization that links stem cell researchers from all disciplines across Germany,” says Claudia Waskow. “This is of paramount importance because stem cell biology is a cross-sectional field involving researchers from a wide range of disciplines. The annual meetings and other networking formats result in fantastic collaborations. The GSCN is also an excellent hub organizing and coordinating public outreach aiming at informing and educating the public about our research – I want to help shape these key activities as president.”
Two-year presidency: Advancing international cooperation, expanding mentoring program, promoting female researchers
Claudia Waskow has set three priorities for her two-year term from 2022 to 2024. First and foremost is the expansion of collaborations at the national and international level. “We already work very closely with regional networks such as the Stem Cell Network in North Rhine-Westphalia. I would like to push this for comparable organizations in Europe as well,” says Waskow. In addition, the mentoring program, which started a year ago with five mentees, will be a focus of her presidency. “I would like to expand the program launched by my colleagues Marieke Essers, Insa Schröder, Germán Camargo Ortega and Karin Höhne to support young scientists.” Claudia Waskow also wants to intensify her networking activities to promote female scientists: “I want to help ensure that women in stem cell research have equal opportunities when it comes to appointments. This includes increasing the visibility of women in stem cell research.”
Claudia Waskow has been shaping the work of the GSCN for many years. She has been part of the Extended Board since 2014 and has been on the five-person Executive Board for the past two years. Together with the Executive Board, Claudia Waskow will steer the strategic direction and activities of the network as President, supported by the administrative office, which is located at the Max Delbrück Center in Berlin.
Stem cell research for healthy aging
At the Leibniz Institute on Aging – Fritz Lipmann Institute (FLI), which has been a member of the GSCN since 2014, one of many topics of research is the fundamental mechanisms of stem cell regulation. This involves, for example, the question of how the organism decides whether hematopoietic and neuronal stem cells differentiate into different cell types of the blood or nervous system, respectively, or whether the stem cells self-renew. “These are the big questions that concern us stem cell biologists,” says Claudia Waskow. “If you understand the regulation, you could support regenerative processes in the body, either by transplanting stem cells or by trying to influence their regulation in the body.” Hematopoietic stem cells and immune cells, which are at the center of Waskow’s research at the FLI, are already routinely used in the treatment of many hematological diseases to support vital hematopoiesis.
Contact
Kristina Vaillant
Manager Communication
Phone: 03641-65-6373
Email: presse@leibniz-fli.de
------------------------------------------------------------------------------------------------------------------------
Background information
The Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) – upon its inauguration in 2004 – was the first German research organization dedicated to research on the process of aging. More than 350 employees from around 40 nations explore the molecular mechanisms underlying aging processes and age-associated diseases. For more information, please visit http://www.leibniz-fli.de.
The Leibniz Association connects 97 independent research institutions that range in focus from natural, engineering, and environmental sciences to economics, spatial, and social sciences and the humanities. Leibniz Institutes address issues of social, economic, and ecological relevance. They conduct basic and applied research, including in the interdisciplinary Leibniz Research Alliances, maintain scientific infrastructure, and provide research-based services. The Leibniz Association identifies focus areas for knowledge transfer, particularly with the Leibniz research museums. It advises and informs policymakers, science, industry, and the general public. Leibniz institutions collaborate intensively with universities – including in the form of Leibniz ScienceCampi – as well as with industry and other partners at home and abroad. They are subject to a transparent, independent evaluation procedure. Because of their importance for the country as a whole, the Leibniz Association Institutes are funded jointly by Germany’s central and regional governments. The Leibniz Institutes employ around 20,500 people, including 11,500 researchers. The financial volume amounts to 2 billion euros. For more information: http://www.leibniz-gemeinschaft.de/en/.
Prof. Dr. Claudia Waskow, President of the German Stem Cell Network (GSCN)
Arne Sattler
GSCN/Arne Sattler
Criteria of this press release:
Journalists, Scientists and scholars, all interested persons
Biology, Medicine
transregional, national
Personnel announcements
English
Prof. Dr. Claudia Waskow, President of the German Stem Cell Network (GSCN)
Arne Sattler
GSCN/Arne Sattler
You can combine search terms with and, or and/or not, e.g. Philo not logy.
You can use brackets to separate combinations from each other, e.g. (Philo not logy) or (Psycho and logy).
Coherent groups of words will be located as complete phrases if you put them into quotation marks, e.g. “Federal Republic of Germany”.
You can also use the advanced search without entering search terms. It will then follow the criteria you have selected (e.g. country or subject area).
If you have not selected any criteria in a given category, the entire category will be searched (e.g. all subject areas or all countries).
